Our analysis revealed the strongest positive correlation between WNT7B, and genes co-expressed with 19 and 24 anti-cancer drugs, and a negative correlation with 6 and 4 drugs, respectively (Fig. 11A, B). This evidence concerns the gene WNT7B and cancer.